Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PHOENIX BIOTECH ACQUISITION CORP.

(PBAXU)
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
10.54(c) 10.13(c) 10.09(c) 10.07(c) 10.09(c) Last
200 121 313 400 4 914 Volume
+4.30% -3.89% -0.39% -0.20% +0.20% Change
More quotes
Company
Phoenix Biotech Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly... 
Sector
Investment Holding Companies
Calendar
-
More about the company
All news about PHOENIX BIOTECH ACQUISITION CORP.
2021PHOENIX BIOTECH ACQUISITION CORP.(NA : PBAX) added to NASDAQ Composite Index
CI
2021Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Tradin..
AQ
2021PHOENIX BIOTECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
2021PHOENIX BIOTECH ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form ..
AQ
2021PHOENIX BIOTECH ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregister..
AQ
2021PHOENIX BIOTECH ACQUISITION : Blank-Check Company Phoenix Biotech Acquisition Raises $175 ..
MT
2021PHOENIX BIOTECH ACQUISITION CORP : . Announces Completion of $175,000,000 Initial Public O..
AQ
2021Phoenix Biotech Acquisition Corp. has completed an IPO in the amount of $155 million.
CI
2021Phoenix Biotech Acquisition Corp. has filed an IPO in the amount of $155 million.
CI
More news
News in other languages on PHOENIX BIOTECH ACQUISITION CORP.
2021L'entreprise à fonds perdus Phoenix Biotech Acquisition lève 175 millions de dollars lo..
More news
Chart PHOENIX BIOTECH ACQUISITION CORP.
Duration : Period :
Phoenix Biotech Acquisition Corp. Technical Analysis Chart | PBAXU | US71902K2042 | MarketScreener
Technical analysis trends PHOENIX BIOTECH ACQUISITION CORP.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Managers and Directors
Christopher B. Ehrlich Chief Executive Officer & Director
Douglas Carl Fisher President
Daniel E. Geffken Chief Financial Officer
Brian G. Atwood Independent Director
Kathy D. LaPorte Independent Director
Sector and Competitors